Correlating Time-Lapse Parameters With aCGH Testing in IVF Treatment (aCGH Study)

Status unconfirmed

Conditions studied: Infertility

In brief

The purpose of this research study protocol is to collect imaging data on embryos followed to blastocyst stage (Day 5-6) and correlate Eeva parameters with array - Comparative Genomic Hybridization (aCGH) results and ongoing pregnancy rates.

Key facts

Study ID

NCT02141685

Run by

Progyny, Inc.

People needed

50

Starts

2014-05-01

Expected to finish

2016-02-01

Last updated by the study team

2015-07-13

Who can join

Age: 18 and older, up to 43. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Subject is ≤43 years of age.
• Women undergoing IVF treatment with planned aCGH testing using her own eggs or donor eggs.
• Antral Follicle Count ≥ 6 at time of cycle start
• Baseline (day 2-3 of cycling) FSH ≤ 15 mIU/ml
• Antimüllerian Hormone level ≥ 0.5 ng/mL
• Fertilization using only ejaculated sperm (fresh or frozen) - no surgically retrieved sperm.
• Willing to have all 2PN embryos monitored by Eeva
• Not previously enrolled in this study.
• Willing to comply with study protocol and procedures and able to speak English.
• Willing to provide written informed consent.

You may not qualify if…

• BMI ≥ 40
• Prior IVF cycle with < 4 x 2PN
• Planned Day 3 Assisted Hatching

Where it is running

• Main Line Fertility — Bryn Mawr, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.